ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

SEEL Seelos Therapeutics Inc

0.2953
-0.0047 (-1.57%)
Last Updated: 09:57:54
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000808k336k406k
Operating Income -27.37M-14.01M-21.24M-17.41M-18.26M-8.93M-10.95M-12.6M
Pre Tax Income -27.26M-14M-21.27M-19.6M-18.66M-13.43M-29.5M10.5M
Net Income -27.26M-14M-21.27M-19.6M-18.66M-13.43M-29.5M10.5M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -27.14M-13.78M-21.24M-17.41M-18.26M-13.17M-10.95M-12.6M
EBITDA -27.37M-14.01M-21.24M-17.41M-18.26M-8.93M-10.95M-12.6M
Year End December 30 2023 20162017201820192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 5.76M00375k0002.2M
Operating Income -13.39M-10.67M-9.15M-29.75M-18.76M-61.67M-70.92M-40.5M
Pre Tax Income -7.43M-11.75M-9.22M-51.26M-19.1M-66.05M-73.53M-37.88M
Net Income -7.43M321k-9.24M-51.26M-19.1M-66.05M-73.53M-37.88M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.9610.021-9.811-1.896-0.35-0.626-0.686-0.235
EBIT -13.43M-11.02M-9.44M-34.88M-18.76M-61.29M-70.92M-46.85M
EBITDA -13.1M-10.57M-9.11M-29.75M-18.76M-61.67M-70.92M-40.5M

Your Recent History

Delayed Upgrade Clock